Marksans Pharma

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue220.60242.69237.39262.68339.99
Expenses176.10208.09198.99220.38263.65
EBITDA53.2343.3046.1049.4283.63
EBIT44.7334.8738.6342.5876.62
Profit Before Tax44.5034.6038.4042.3076.33
Net Profit31.2925.2932.9932.0263.20
Financial Ratios
Operating Profit Margin26.01%17.94%20.47%19.42%27.10%
Net Profit Margin15.29%10.48%14.65%12.58%20.48%
Earning Per Share (Diluted)0.690.560.730.711.39
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ